查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2026932

精準診斷市場預測至2034年－按類型、應用、最終用戶和地區分類的全球分析

Precision Diagnostics Market Forecasts to 2034 - Global Analysis By Type (Direct to Consumer Tests, Esoteric Tests, Genetic Tests and Other Types), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球精準診斷市場規模將達到 1,193 億美元，並在預測期內以 14.6% 的複合年成長率成長，到 2034 年將達到 3,550 億美元。

能夠實現高度精準和個人化醫療檢測的先進診斷技術市場被稱為「精準診斷市場」。精準診斷是指利用蛋白質體學、基因組學和分子診斷等先進技術，在分子層面分析患者檢體。這項技術能夠準確地識別與特定疾病相關的基因變異、生物標記和其他分子指標。

根據世界衛生組織（世衛組織）的數據，截至 2021 年 5 月，全球已有 163,312,429 人感染了 COVID-19。

人們對醫療保健的認知不斷提高

患者和醫療專業人員越來越意識到精準診斷對治療結果的突破性影響。越來越多人認知到其益處，例如早期發現疾病、制定個人化治療方案以及獲得更好的治療效果的可能性。此外，越來越多的患者俱備相關知識，他們希望獲得尖端診斷工具，以便從分子層面更深入地了解自身健康狀況。

前期成本高

採用先進技術需要前期對專用設備、基礎設施和熟練人員進行大量投資。次世代定序和分子譜分析就是很好的例子。這些高昂的初始成本為醫療機構和診斷檢查室帶來了巨大的財務挑戰，可能會限制患者獲得某些先進的診斷服務。然而，更令人擔憂的是，這些成本不僅包括技術購置費用，還包括醫護人員的大量訓練課程費用。

慢性病盛行率增加

癌症、心血管疾病和神經系統疾病等疾病在全球日益加重，凸顯了對精準快速診斷工具的迫切需求。精準診斷結合了前沿分子技術和個人化醫療方法，能夠識別與多種慢性疾病相關的特定基因突變、生物標記和分子特徵。此外，由於這些疾病通常需要特殊治療，準確全面的診斷對於治療成功和改善患者預後至關重要。

對資料隱私和安全的擔憂

高精度診斷需要收集和分析高度敏感的患者信息，包括基因和分子數據，因此，強力的數據保護措施至關重要。患者和醫療專業人員都擔心個人資訊可能被濫用、資料外洩以及個人健康資訊遭到未授權存取。然而，解決這些問題需要嚴格遵守GDPR和HIPAA等資料保護法律，並且需要對網路安全基礎設施進行大量投資。

新冠疫情的影響：

疫情凸顯了快速準確診斷的重要性，但也造成了一些混亂，例如非緊急診斷程序的延遲以及資源被轉移到新冠病毒檢測上。分子診斷，特別是PCR檢測的需求激增，但這導致了供應鏈中斷和醫院基礎設施超負荷運作。傳統的診斷環境也受到了遠端醫療和遠距離診斷趨勢的影響。

在預測期內，基因檢測領域預計將成為規模最大的領域。

隨著精準醫療的興起，基因檢測領域已佔據最大的市場佔有率。包括分子譜分析和次世代定序的基因檢測需求正在迅速成長。這些檢測能夠全面了解個體的基因組成，從而發現特定的基因差異、疾病易感性以及潛在的治療反應。此外，遺傳性疾病盛行率的不斷上升以及人們對個人化醫療日益成長的認知，也推動了基因檢測在疾病診斷、風險評估和治療方案製定中的應用。

在預測期內，腫瘤學領域預計將呈現最高的複合年成長率。

隨著分子檢測、液態生物檢體和基因組分析等技術的進步，腫瘤學領域正迅速發展，這些技術使得識別與各種癌症類型相關的特定基因改變和生物標記成為可能。這種精準度使腫瘤科醫師能夠根據每位患者腫瘤特異性的基因譜量身訂做治療方案並最佳化治療效果。全球癌症發生率的不斷上升以及我們對癌症分子機制認知的不斷加深，推動了腫瘤學領域對更精準診斷技術的需求。

市佔率最大的地區：

隨著癌症和心血管疾病等慢性病的盛行率上升，對先進、精準診斷工具的需求日益成長，預計亞太地區將在預測期內佔據最大的市場佔有率。此外，該地區中產階級人口不斷壯大，醫療保健水準不斷提高，尤其注重預防醫學實踐。精準診斷的概念，即透過個人化和標靶治療來改善患者預後，與這些不斷發展的醫療保健理念不謀而合。

複合年成長率最高的地區：

亞太地區正經歷強勁成長，這主要得益於科技的快速發展和醫療保健服務的不斷普及。中國、日本和印度等國家在研發、基礎設施和醫療保健領域投入巨資，為尖端診斷技術的應用創造了有利環境。亞太地區優先發展醫療保健基礎設施，持續增加研發投入，並已成功實現精準醫療模式轉移，可望成為推動全球精準診斷市場成長和擴張的重要力量。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章：全球精準診斷市場：依類型分類

  • 消費者測試
  • 特殊檢查
  • 基因檢測
  • 其他類型

第6章 全球精準診斷市場：依應用分類

  • 心血管系統
  • 免疫學
  • 腫瘤學
  • 呼吸系統疾病
  • 其他用途

第7章 全球精準診斷市場：依最終用戶分類

  • 臨床檢查室
  • 居家照護
  • 醫院
  • 其他最終用戶

第8章 全球精準診斷市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第9章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章：公司簡介

  • Abbott
  • Bayer AG
  • Koninklijke Philips NV
  • Lantheus Medical Imaging, Inc.
  • Novartis AG
  • QIAGEN
  • Quest Diagnostics Incorporated
  • Sanofi
  • Siemens Healthineers AG
  • Swiss Precision Diagnostics GmbH
Product Code: SMRC24695

According to Stratistics MRC, the Global Precision Diagnostics Market is accounted for $119.3 billion in 2026 and is expected to reach $355.0 billion by 2034 growing at a CAGR of 14.6% during the forecast period. The market for improved diagnostic technologies that enable very precise and customized medical testing is known as the "precision diagnostics market." Precision diagnostics entails the molecular analysis of patient samples using advanced methods, including proteomics, genomics, and molecular diagnostics. With this method, genetic variants, biomarkers, and other molecular indicators linked to certain diseases can be precisely identified.

According to the World Health Organization (WHO), in May 2021, 163,312,429 people worldwide were affected by COVID-19.

Market Dynamics:

Driver:

Increasing healthcare awareness

Patients and healthcare professionals' awareness of the revolutionary effect accurate diagnosis can have on treatment results is growing. An increasing number of people are becoming aware of the benefits of early disease detection, customized treatment regimens, and the possibility of better patient outcomes. Additionally, more and more sophisticated patients are asking for access to state-of-the-art diagnostic tools that can offer an in-depth understanding of their molecular health.

Restraint:

High upfront costs

Advanced technology adoption requires large upfront investments in specialized machinery, infrastructure, and skilled employees. Some instances of these are next-generation sequencing and molecular profiling. These higher initial costs might pose an economic challenge for medical facilities, and diagnostic labs and potentially restrict patient access to specific precision diagnostic services. However, the financial burden is further increased by the fact that the expenses extend beyond the purchase of technology and involve thorough training courses for medical professionals.

Opportunity:

Growing prevalence of chronic diseases

Accurate and timely diagnostic tools are becoming more and more necessary due to the rising worldwide burden of diseases like cancer, cardiovascular diseases, and neurological disorders. The identification of certain genetic mutations, biomarkers, and molecular signatures associated with a range of chronic conditions is made possible by precision diagnostics, which includes cutting-edge molecular technology and customized medicine techniques. Additionally, accurate and thorough diagnoses are essential for successful intervention and better patient outcomes since these illnesses often require specialized therapies.

Threat:

Data privacy and security concerns

Ensuring strong data protection measures is crucial because precision diagnostics requires the collection and analysis of extremely sensitive patient information, including genetic and molecular data. Patients and healthcare providers are concerned about the possibility of misuse, data breaches, and unauthorized access to personal health information. However, strict adherence to data protection laws, such as GDPR and HIPAA, is necessary to address these issues, necessitating substantial expenditures in cybersecurity infrastructure.

Covid-19 Impact:

While the pandemic emphasized the significance of rapid and accurate diagnosis, delays in non-urgent diagnostic procedures and the redirection of resources toward COVID-19 testing caused disruptions. Demand for molecular diagnostics, especially PCR-based tests, surged in the industry, but supply chain disruptions and overloaded hospital infrastructures posed problems. Traditional diagnostic settings were also impacted by a shift in emphasis toward telemedicine and remote diagnostics.

The genetic tests segment is expected to be the largest during the forecast period

With the growing popularity of precision medicine, the genetic testing sector held the largest market share. Demand for genetic tests, such as molecular profiling and next-generation sequencing, is rapidly rising. An individual's genetic composition can be fully recognized by these tests, which can detect certain genetic differences, illness susceptibility, and possible treatment reactions. Additionally, the use of genetic tests for illness diagnosis, risk assessment, and treatment planning is being driven by the rising frequency of genetic illnesses and the increasing awareness of individualized healthcare.

The oncology segment is expected to have the highest CAGR during the forecast period

Because molecular testing, liquid biopsies, and genomic profiling have made it possible to identify particular genetic changes and biomarkers linked to various cancer types, the oncology sector is expanding rapidly. With this level of accuracy, oncologists can optimize therapeutic outcomes by customizing treatment plans based on each patient's tumor's unique genetic profile. Accurate diagnostic techniques for oncology are in greater demand due to the rising global prevalence of cancer and our growing understanding of its molecular basis.

Region with largest share:

Because the demand for sophisticated and accurate diagnostic tools has increased due to the rising prevalence of chronic diseases, including cancer and cardiovascular disorders, the Asia-Pacific region is anticipated to hold the largest share of the market over the forecasted period. In addition, the area is experiencing a rise in the middle-class population and healthcare expertise, with a particular emphasis on preventive healthcare practices. Moreover, the precision diagnostic tenets of tailored and targeted interventions for better patient outcomes are in accordance with this movement in healthcare perspectives.

Region with highest CAGR:

The Asia-Pacific region is growing profitably as a result of the rapid advancement in technology and the growing availability of healthcare services. Nations like China, Japan, and India have invested large investments in R&D, infrastructure, and healthcare, providing a climate that is favorable to the adoption of cutting-edge diagnostic technology. The Asia Pacific region will definitely be a major force behind the growth and expansion of the precision diagnostics market on a global scale as it continues to prioritize the development of healthcare infrastructure, invest in research and innovation, and experience a paradigm shift towards precision medicine.

Key players in the market

Some of the key players in Precision Diagnostics market include Abbott, Bayer AG, Koninklijke Philips N.V., Lantheus Medical Imaging, Inc., Novartis AG, QIAGEN, Quest Diagnostics Incorporated, Sanofi, Siemens Healthineers AG and Swiss Precision Diagnostics GmbH.

Key Developments:

In October 2023, Bayer AG has entered into an antibody discovery, option, and license agreement with Twist Bioscience Corporation, a company offering high-quality synthetic DNA using its silicon platform.

In September 2023, Abbott signs definitive agreement to acquire Bigfoot Biomedical, which develops smart insulin management systems for individuals with diabetes. As part of the acquisition, Abbott will use Bigfoot Unity with its FreeStyle Libre technology, which uses a customer smartphone app connected to a cloud-based online portal.

In May 2023, Bayer has secured a long-term structured renewable energy credit purchase agreement with Cat Creek Energy that will generate 1.4 terawatt-hours of clean electricity annually, equivalent to the energy consumption of 150,000 households.

Types Covered:

  • Direct to Consumer Tests
  • Esoteric Tests
  • Genetic Tests
  • Other Types

Applications Covered:

  • Cardiovascular
  • Immunology
  • Oncology
  • Respiratory Diseases
  • Other Applications

End Users Covered:

  • Clinical Laboratories
  • Homecare
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Precision Diagnostics Market, By Type

  • 5.1 Introduction
  • 5.2 Direct to Consumer Tests
  • 5.3 Esoteric Tests
  • 5.4 Genetic Tests
  • 5.5 Other Types

6 Global Precision Diagnostics Market, By Application

  • 6.1 Introduction
  • 6.2 Cardiovascular
  • 6.3 Immunology
  • 6.4 Oncology
  • 6.5 Respiratory Diseases
  • 6.6 Other Applications

7 Global Precision Diagnostics Market, By End User

  • 7.1 Introduction
  • 7.2 Clinical Laboratories
  • 7.3 Homecare
  • 7.4 Hospitals
  • 7.5 Other End Users

8 Global Precision Diagnostics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott
  • 10.2 Bayer AG
  • 10.3 Koninklijke Philips N.V.
  • 10.4 Lantheus Medical Imaging, Inc.
  • 10.5 Novartis AG
  • 10.6 QIAGEN
  • 10.7 Quest Diagnostics Incorporated
  • 10.8 Sanofi
  • 10.9 Siemens Healthineers AG
  • 10.10 Swiss Precision Diagnostics GmbH

List of Tables

  • Table 1 Global Precision Diagnostics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Precision Diagnostics Market Outlook, By Type (2023-2034) ($MN)
  • Table 3 Global Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2023-2034) ($MN)
  • Table 4 Global Precision Diagnostics Market Outlook, By Esoteric Tests (2023-2034) ($MN)
  • Table 5 Global Precision Diagnostics Market Outlook, By Genetic Tests (2023-2034) ($MN)
  • Table 6 Global Precision Diagnostics Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 7 Global Precision Diagnostics Market Outlook, By Application (2023-2034) ($MN)
  • Table 8 Global Precision Diagnostics Market Outlook, By Cardiovascular (2023-2034) ($MN)
  • Table 9 Global Precision Diagnostics Market Outlook, By Immunology (2023-2034) ($MN)
  • Table 10 Global Precision Diagnostics Market Outlook, By Oncology (2023-2034) ($MN)
  • Table 11 Global Precision Diagnostics Market Outlook, By Respiratory Diseases (2023-2034) ($MN)
  • Table 12 Global Precision Diagnostics Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 13 Global Precision Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • Table 14 Global Precision Diagnostics Market Outlook, By Clinical Laboratories (2023-2034) ($MN)
  • Table 15 Global Precision Diagnostics Market Outlook, By Homecare (2023-2034) ($MN)
  • Table 16 Global Precision Diagnostics Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 17 Global Precision Diagnostics Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 18 North America Precision Diagnostics Market Outlook, By Country (2023-2034) ($MN)
  • Table 19 North America Precision Diagnostics Market Outlook, By Type (2023-2034) ($MN)
  • Table 20 North America Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2023-2034) ($MN)
  • Table 21 North America Precision Diagnostics Market Outlook, By Esoteric Tests (2023-2034) ($MN)
  • Table 22 North America Precision Diagnostics Market Outlook, By Genetic Tests (2023-2034) ($MN)
  • Table 23 North America Precision Diagnostics Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 24 North America Precision Diagnostics Market Outlook, By Application (2023-2034) ($MN)
  • Table 25 North America Precision Diagnostics Market Outlook, By Cardiovascular (2023-2034) ($MN)
  • Table 26 North America Precision Diagnostics Market Outlook, By Immunology (2023-2034) ($MN)
  • Table 27 North America Precision Diagnostics Market Outlook, By Oncology (2023-2034) ($MN)
  • Table 28 North America Precision Diagnostics Market Outlook, By Respiratory Diseases (2023-2034) ($MN)
  • Table 29 North America Precision Diagnostics Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 30 North America Precision Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • Table 31 North America Precision Diagnostics Market Outlook, By Clinical Laboratories (2023-2034) ($MN)
  • Table 32 North America Precision Diagnostics Market Outlook, By Homecare (2023-2034) ($MN)
  • Table 33 North America Precision Diagnostics Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 34 North America Precision Diagnostics Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 35 Europe Precision Diagnostics Market Outlook, By Country (2023-2034) ($MN)
  • Table 36 Europe Precision Diagnostics Market Outlook, By Type (2023-2034) ($MN)
  • Table 37 Europe Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2023-2034) ($MN)
  • Table 38 Europe Precision Diagnostics Market Outlook, By Esoteric Tests (2023-2034) ($MN)
  • Table 39 Europe Precision Diagnostics Market Outlook, By Genetic Tests (2023-2034) ($MN)
  • Table 40 Europe Precision Diagnostics Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 41 Europe Precision Diagnostics Market Outlook, By Application (2023-2034) ($MN)
  • Table 42 Europe Precision Diagnostics Market Outlook, By Cardiovascular (2023-2034) ($MN)
  • Table 43 Europe Precision Diagnostics Market Outlook, By Immunology (2023-2034) ($MN)
  • Table 44 Europe Precision Diagnostics Market Outlook, By Oncology (2023-2034) ($MN)
  • Table 45 Europe Precision Diagnostics Market Outlook, By Respiratory Diseases (2023-2034) ($MN)
  • Table 46 Europe Precision Diagnostics Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 47 Europe Precision Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • Table 48 Europe Precision Diagnostics Market Outlook, By Clinical Laboratories (2023-2034) ($MN)
  • Table 49 Europe Precision Diagnostics Market Outlook, By Homecare (2023-2034) ($MN)
  • Table 50 Europe Precision Diagnostics Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 51 Europe Precision Diagnostics Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 52 Asia Pacific Precision Diagnostics Market Outlook, By Country (2023-2034) ($MN)
  • Table 53 Asia Pacific Precision Diagnostics Market Outlook, By Type (2023-2034) ($MN)
  • Table 54 Asia Pacific Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2023-2034) ($MN)
  • Table 55 Asia Pacific Precision Diagnostics Market Outlook, By Esoteric Tests (2023-2034) ($MN)
  • Table 56 Asia Pacific Precision Diagnostics Market Outlook, By Genetic Tests (2023-2034) ($MN)
  • Table 57 Asia Pacific Precision Diagnostics Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 58 Asia Pacific Precision Diagnostics Market Outlook, By Application (2023-2034) ($MN)
  • Table 59 Asia Pacific Precision Diagnostics Market Outlook, By Cardiovascular (2023-2034) ($MN)
  • Table 60 Asia Pacific Precision Diagnostics Market Outlook, By Immunology (2023-2034) ($MN)
  • Table 61 Asia Pacific Precision Diagnostics Market Outlook, By Oncology (2023-2034) ($MN)
  • Table 62 Asia Pacific Precision Diagnostics Market Outlook, By Respiratory Diseases (2023-2034) ($MN)
  • Table 63 Asia Pacific Precision Diagnostics Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 64 Asia Pacific Precision Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • Table 65 Asia Pacific Precision Diagnostics Market Outlook, By Clinical Laboratories (2023-2034) ($MN)
  • Table 66 Asia Pacific Precision Diagnostics Market Outlook, By Homecare (2023-2034) ($MN)
  • Table 67 Asia Pacific Precision Diagnostics Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 68 Asia Pacific Precision Diagnostics Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 69 South America Precision Diagnostics Market Outlook, By Country (2023-2034) ($MN)
  • Table 70 South America Precision Diagnostics Market Outlook, By Type (2023-2034) ($MN)
  • Table 71 South America Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2023-2034) ($MN)
  • Table 72 South America Precision Diagnostics Market Outlook, By Esoteric Tests (2023-2034) ($MN)
  • Table 73 South America Precision Diagnostics Market Outlook, By Genetic Tests (2023-2034) ($MN)
  • Table 74 South America Precision Diagnostics Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 75 South America Precision Diagnostics Market Outlook, By Application (2023-2034) ($MN)
  • Table 76 South America Precision Diagnostics Market Outlook, By Cardiovascular (2023-2034) ($MN)
  • Table 77 South America Precision Diagnostics Market Outlook, By Immunology (2023-2034) ($MN)
  • Table 78 South America Precision Diagnostics Market Outlook, By Oncology (2023-2034) ($MN)
  • Table 79 South America Precision Diagnostics Market Outlook, By Respiratory Diseases (2023-2034) ($MN)
  • Table 80 South America Precision Diagnostics Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 81 South America Precision Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • Table 82 South America Precision Diagnostics Market Outlook, By Clinical Laboratories (2023-2034) ($MN)
  • Table 83 South America Precision Diagnostics Market Outlook, By Homecare (2023-2034) ($MN)
  • Table 84 South America Precision Diagnostics Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 85 South America Precision Diagnostics Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 86 Middle East & Africa Precision Diagnostics Market Outlook, By Country (2023-2034) ($MN)
  • Table 87 Middle East & Africa Precision Diagnostics Market Outlook, By Type (2023-2034) ($MN)
  • Table 88 Middle East & Africa Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2023-2034) ($MN)
  • Table 89 Middle East & Africa Precision Diagnostics Market Outlook, By Esoteric Tests (2023-2034) ($MN)
  • Table 90 Middle East & Africa Precision Diagnostics Market Outlook, By Genetic Tests (2023-2034) ($MN)
  • Table 91 Middle East & Africa Precision Diagnostics Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 92 Middle East & Africa Precision Diagnostics Market Outlook, By Application (2023-2034) ($MN)
  • Table 93 Middle East & Africa Precision Diagnostics Market Outlook, By Cardiovascular (2023-2034) ($MN)
  • Table 94 Middle East & Africa Precision Diagnostics Market Outlook, By Immunology (2023-2034) ($MN)
  • Table 95 Middle East & Africa Precision Diagnostics Market Outlook, By Oncology (2023-2034) ($MN)
  • Table 96 Middle East & Africa Precision Diagnostics Market Outlook, By Respiratory Diseases (2023-2034) ($MN)
  • Table 97 Middle East & Africa Precision Diagnostics Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 98 Middle East & Africa Precision Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • Table 99 Middle East & Africa Precision Diagnostics Market Outlook, By Clinical Laboratories (2023-2034) ($MN)
  • Table 100 Middle East & Africa Precision Diagnostics Market Outlook, By Homecare (2023-2034) ($MN)
  • Table 101 Middle East & Africa Precision Diagnostics Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 102 Middle East & Africa Precision Diagnostics Market Outlook, By Other End Users (2023-2034) ($MN)